Pregled bibliografske jedinice broj: 177369
In vitro activity of dimethylarsinic acid against human leukaemia and multiple myeloma cell lines
In vitro activity of dimethylarsinic acid against human leukaemia and multiple myeloma cell lines // Cancer chematotherapy and pharmacology, 51 (2003), 5; 427-432 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 177369 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
In vitro activity of dimethylarsinic acid against human leukaemia and multiple myeloma cell lines
Autori
Duzkale, H. ; Jilani, I. ; Oršolić, Nada ; Zingaro, R.A. ; Golemović, Mirna ; Giles, F. ; Kantarjian, H. ; Albitar, M. ; Freireich, E.J. ; Verstovšek, Srđan
Izvornik
Cancer chematotherapy and pharmacology (0344-5704) 51
(2003), 5;
427-432
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Dimethylarsinic acid; Arsenic trioxide
Sažetak
Arsenic trioxide (As2O3), an inorganic arsenic compound, has recently been approved for the treatment of relapsed or refractory acute promyelocytic leukemia. However, systemic toxicity associated with As2O3 treatment remains a problem. Inorganic arsenic is detoxified in vivo by methylation reactions into organic arsenic compounds that are less toxic. Methods and results: We investigated the antiproliferative and cytotoxic activity of dimethylarsinic acid(DMAA), an organic arsenic derivative and major metabolic by-product of As2O3, against a panel of eight leukemia and multiple myeloma cell lines. As2O3 was tested in comparison. In clonogenic assay, the average concentration of DMAA that suppressed cell colony growth by 50% was 0.5 - 1 mM, while for As2O3 it was on average 1 - 2 lM. At those concentrations DMAA and As2O3 had significantly less e.ect on colony growth of normal progenitor cells. Cytotoxic doses of DMAA and As2O3 in 3-day trypan blue dye exclusion assay experiments were similar to doses efective in clonogenic assay. Assessment of apoptosis by annexin V assay revealed a high rate of apoptosis in all cell lines treated with DMAA and As2O3, but signi.cantly less efect on normal progenitor cells. DMAA, unlike As2O3, had no efect on the maturation of leukemic cells. Conclusions: DMAA exerts diferential antiproliferative and cytotoxic activity against leukemia and multiple myeloma cells, with no significant efect on normal progenitor cells. However, concentrations of DMAA needed to achieve such efficacy are up to 1000 times those of As2O3. Evaluation of novel organic arsenic that would combine the high efficacy of As2O3 and the low toxicity of DMAA is warranted.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE